Comment on: Favipiravir, an antiviral for COVID-19?

被引：2
|
作者：
Chachaima-Mar, Jorge [1 ,2 ]
Perez-Castilla, Jesus [3 ]
机构：
[1] Univ Peruana Cayetano Heredia, Sch Med, Lima, Peru
[2] REDECS, Red Eficacia Clin & Sanitaria, Lima, Peru
[3] Natl Univ St Anthony Abbot Cusco, Sch Med, Cuzco, Peru
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2021年 / 76卷 / 01期
关键词：
D O I：
10.1093/jac/dkaa378
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：279 / 280
页数：3
相关论文
共 50 条
  • [1] Favipiravir, an antiviral for COVID-19?
    Coomes, Eric A.
    Haghbayan, Hourmazd
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 (07) : 2013 - 2014
  • [2] Antiviral therapy for COVID-19: Derivation of optimal strategy based on past antiviral and favipiravir experiences
    Shiraki, Kimiyasu
    Sato, Noriaki
    Sakai, Kaoru
    Matsumoto, Shirou
    Kaszynski, Richard H.
    Takemoto, Masaya
    PHARMACOLOGY & THERAPEUTICS, 2022, 235
  • [3] Favipiravir for treating COVID-19
    Korula, Pritish
    Alexander, Hanna
    John, Jisha Sara
    Kirubakaran, Richard
    Singh, Bhagteshwar
    Tharyan, Prathap
    Rupali, Priscilla
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2024, (02):
  • [4] Alectinib, COVID-19 and favipiravir
    Mungmunpuntipantip, Rujittika
    Wiwanitkit, Viroj
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (07) : 1810 - 1810
  • [5] Highly selective and sensitive potentiometric determination of favipiravir in COVID-19 antiviral drug formulations
    Topcu, Cihan
    Aydin, Senanur
    Atasoy, Betul Hilal
    Yilmaz, Rabia Rana
    Coldur, Fatih
    Caglar, Bulent
    MICROCHEMICAL JOURNAL, 2024, 205
  • [6] Role of favipiravir in the treatment of COVID-19
    Joshi, Shashank
    Parkar, Jalil
    Ansari, Abdul
    Vora, Agam
    Talwar, Deepak
    Tiwaskar, Mangesh
    Patil, Saiprasad
    Barkate, Hanmant
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 102 : 501 - 508
  • [7] Favipiravir for COVID-19 in a Patient on Hemodialysis
    Hirai, Daisuke
    Yamashita, Daisuke
    Seta, Koichi
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2021, 77 (01) : 153 - 154
  • [8] Favipiravir and COVID-19: A Simplified Summary
    Ghasemnejad-Berenji, Morteza
    Pashapour, Sarvin
    DRUG RESEARCH, 2021, 71 (03) : 166 - 170
  • [9] Favipiravir Use in COVID-19 Treatment
    Kara, Emre
    Inkaya, Ahmet Cagkan
    Demirkan, Kutay
    Unal, Serhat
    FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI, 2021, 26 (01): : 1 - 11
  • [10] Favipiravir as an Antiviral Agent in Coronavirus Disease 2019 (COVID-19): Same Script, Different Cast?
    Dauby, Nicolas
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (03) : E847 - E848
12345